Last reviewed · How we verify
Fumarate, Tenofovir Disoproxil
Fumarate, Tenofovir Disoproxil is a Small molecule drug developed by ANRS, Emerging Infectious Diseases. It is currently FDA-approved. Also known as: TDF.
At a glance
| Generic name | Fumarate, Tenofovir Disoproxil |
|---|---|
| Also known as | TDF |
| Sponsor | ANRS, Emerging Infectious Diseases |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention (NA)
- A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) (PHASE3)
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) (PHASE3)
- Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men (PHASE2, PHASE3)
- Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- Antiviral Clinical Trial for Long Covid-19 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fumarate, Tenofovir Disoproxil CI brief — competitive landscape report
- Fumarate, Tenofovir Disoproxil updates RSS · CI watch RSS
- ANRS, Emerging Infectious Diseases portfolio CI
Frequently asked questions about Fumarate, Tenofovir Disoproxil
What is Fumarate, Tenofovir Disoproxil?
Fumarate, Tenofovir Disoproxil is a Small molecule drug developed by ANRS, Emerging Infectious Diseases.
Who makes Fumarate, Tenofovir Disoproxil?
Fumarate, Tenofovir Disoproxil is developed and marketed by ANRS, Emerging Infectious Diseases (see full ANRS, Emerging Infectious Diseases pipeline at /company/anrs-emerging-infectious-diseases).
Is Fumarate, Tenofovir Disoproxil also known as anything else?
Fumarate, Tenofovir Disoproxil is also known as TDF.
What development phase is Fumarate, Tenofovir Disoproxil in?
Fumarate, Tenofovir Disoproxil is FDA-approved (marketed).
Related
- Manufacturer: ANRS, Emerging Infectious Diseases — full pipeline
- Also known as: TDF
- Compare: Fumarate, Tenofovir Disoproxil vs similar drugs
- Pricing: Fumarate, Tenofovir Disoproxil cost, discount & access